[F-18]-Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) as a Diagnostic for Hip Endoprosthesis Loosening;Die [F-18]-Fluorodeoxyglucose (FDG) Positronenemissionstomographie (PET) als Differenzialdiagnostikum der Hüftendoprothesenlockerung

Zeitschrift fur Orthopadie und Ihre Grenzgebiete

Volumn 141, Issue 5, 2003, Pages 540-546

  Mumme, T ^a   Reinartz, P ^a   Cremerius, U ^a   Hermanns, B ^a   Muller Rath R ^a   Neuss, M ^a   Bull U ^a   Wirtz, D C ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Endoprostheses; FDG PET; Infection; Loosening; Wear of polyethylene

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; ASEPTIC NECROSIS; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENDOPROSTHESIS LOOSENING; FEMALE; GLUCOSE METABOLISM; HIP PROSTHESIS; HISTOPATHOLOGY; HUMAN; INTRAOPERATIVE PERIOD; LEG PROSTHESIS; MALE; POSITRON EMISSION TOMOGRAPHY; PROSTHESIS LOOSENING; QUALITATIVE DIAGNOSIS; SEPSIS; TISSUE CULTURE;

EID: 0242383876     PISSN: 00443220     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-42848     Document Type: Article

References (31)

1. Kritz FL. PET scanninng moves into community hospitals. J Nucl Med 1999; 40: 11N-12N
2. Bax JJ, Patton JA, Poldemans D, Elhendy A, Sandler MP. 18-fluorodeoxyglucose imaging with positron emission tomography and single photon emission computed tomography: cardiac applications. Semin Nucl Med 2000; 30: 281-298
3. Coleman RE. Clinical PET in oncology. Clinical positron imaging 1998; 1: 15-30
4. Piert M, Köppe RA, Giordani B, Minoshima S, Kuhl DE. Determination of regional rate constants from dynamic FDG-PET studies in Parkinson's disease. J Nucl Med 1996; 37: 1115-1122
5. Brown RS, Leung JY, Fisher SJ, Frey KA, Ethier SP, Wahl RL. Intratumoral distribution of tritiated fluorodeoxyglucose in breast carcinoma: are inflammatory cells important? J Nucl Med 1995; 36: 1854-1861
6. Fukuda H, Yoshioka S, Watanuki S. Experimental study for cancer-diagnosis with 18FDG: differential diagnosis of inflammation from malignant tumor. Jpn J Nucl Med 1983; 20: 1189-1192
7. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992; 33: 1972-1980
8. Yamada S, Kubota K, Kubota R, Ido T, Tamahashi N. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med 1995; 36: 1301-1306
9. Weisdorf DJ, Craddock PR, Jacobs HS. Glucogenolysis versus glucose transport in human granulocytes: differential activation in phagocytosis and chemotaxis. Blood 1982; 60: 888-893
10. Thara T, Ichiya Y, Kuwabara Y, Otsuka M, Miyake Y, Gunasekera R, Masuda K. High 18F-fluorodeoxyglucose uptake in abdominal abscesses: a PET study. J Comput Assist Tomogr 1989; 13: 829-831
11. Zhuang H, Duarte P, Pourdehand M, Shnier D, Alavi A. Exclusion of chronic osteomyelitis with F-18 Fluorodeoxyglucose Positron Emission Tomographic Imaging. Clin Nucl Med 2000; 25: 281-284
12. Winter F de, Wiele C van de, Vandenberghe S. Coincidence Camera FDG imaging for the diagnosis of chronic orthopedic infections: a feasibility study. J Comput Assist Tomogr 2001; 25: 184-189
13. Guhlmann A, Brecht-Krauss G, Suger G, Glatting G, Kotzerke J, Kinzl L, Reseke SW. Fluorine-18-FDG PET and technetium-99m antigranulocyte antibody scintigraphy in chronic osteomyelitis. J Nucl Med 1998; 39: 2145-2152
14. Schmilz A, Risse HJ, Kälcke T, Grünwald F, Schmitt O. FDG-PET zur Diagnostik und Verlaufskontrolle entzündlicher Prozesse: Erste Ergebnisse aus orthopädischer Sicht. Z Orthop 2000; 138: 407-412
15. Zhuang H, Duarte PS, Pourdehand M, Shnier D, Alavi A. Exclusion of chronic osteomyelitis with F-18 fluorodeoxyglucose positron emission tomographic imaging. Clin Nucl Med 2000; 25: 281-284
16. Winter F de, Wiele C van de, Vogelaers D, Desmet K, Verdonk R, Dierckx RA. FDG-PET as a single technique is more accurate than the combination of bone scan and white blood cell scan in chronic orthopaedic infections. J Nucl Med 2000; 41: 16 P
17. Zhuang H, Duarte PS, Pourdehand M, Pourdehand M, Maes A, van Acker F, Shnier D, Garino JP, Fitzgerald RH, Alavi A. The promising role of 18-FDG-PET in detecting infected lower limb prothesis implants. J Nucl Med 2001; 42: 44-48
18. Acker F van, Nuyts J, Maes A, Vanguckenborne B, Stuyck J, Bellemans J, Vleugers S, Bormans G, Mortelmans L. FDG-PET, 99mTc-HMPAO white blood cell SPET and bone scintigraphy in the evaluation of painful knee arthroplasties. Eur J Nucl Med 2001; 28: 1496-1504
19. Chacko TK, Zhuang H, Stevenson K, Moussavian B, Alavi A. The importance of the location of fluorodeoxyglucose uptake in periprosthetic infection in painful hip prostheses. Nucl Med Commun 2002; 23: 851-855
20. Manthey N, Reinhard P, Moog F, Knesewitsch P, Hahn K, Tatsch K. The use of (18 F)fluorodeoxyglucose positron emission tomography to differentiate between synovitis, loosening and infection of hip and knee prostheses. Nucl Med Commun 2002; 23: 645-653
21. Zhuang H, Chacko T, Hickeson M, Stevenson K, Feng G, Ponzo F, Garino JP, Alavi A. Persistent non-specific FDG uptake on PET imaging following hip arthroplasty. Eur J Nucl Med 2002; 29: 1328-1333
22. Levitsky KA, Hozack WJ, Balderston RA, Röhman RH, Gluckman SJ, Maslack MM, Booth RE Jr. Evaluation of the painful prosthetic joint: relative value of bone scan, sedimentation rate, and joint aspiration. J Arthroplasty 1991; 6: 237-244
23. Friedebold G, Wolff R. Klinische Ergebnisse zementloser Hüftprothesen. Med Welt 1987; 38: 1386-1389
24. Palestro CJ, Torres MA. Radionuclide imaging in orthopedic infections. Semin Nucl Med 1997; 27: 334-345
25. Revell PA, Weightmann B, Freeman MAR, Roberts BV. The production and biology of polyethylene wear debris. Arch Orthop Trauma Surg 1978; 91: 167-181
26. Willert HG, Semlitsch M. Reactions of the articular joint capsule to wear products of artificial joint prostheses. J Biomed Mater Res 1977; 11: 157-164
27. Willert HG, Bretram H, Buchhorn GH. Osteolysis in alloarthroplasty of the hip: the role of ultra-high molecular weight polyethylene wear particles. Clin Orthop 1990; 258: 95-107
28. Kadoya Y, Kobashi A, Ohashi H. Wear and osteolysis in total joint replacements. Acta Orthop Scand 1998; 68: 1-16
29. Wirtz DC, Niethard FU. Etiology, diagnosis and therapy of aseptic hip prosthesis loosening - a status assessment. Z Orthop 1997; 135: 270-280
30. Pauwels EK, Sturm EJ, Bombardieri E. Positron-emission tomography with 18F-fluorodeoxyglucose. Part 1. Biomechanical uptake mechanism and its implication for clinical studies. J Cancer Res Clin Oncol 2000; 126: 549-559
31. Erdman WA, Tamburro F, Jayson HAT, Weatherall PT, Ferry KB, Peshock RM. Osteomyelitis: characteristics and pitfalls of diagnosis with MR imaging. Radiology 1991; 180: 533-539